Form 4: CalciMedica Executive Acquires Stock Options

Eric W. Roberts, Chief Business Officer of CalciMedica, Inc., reports the acquisition of stock options.

Summary

• Eric W. Roberts, the Chief Business Officer of CalciMedica, Inc., filed a Form 4 with the SEC.
• The form reports a transaction on April 23, 2025, where Roberts acquired 160,000 employee stock options with an exercise price of $1.53.
• These options vest in equal monthly installments over a four-year period, beginning March 26, 2025, with an expiration date of April 22, 2035.
• Following the reported transaction, Roberts directly owns 160,000 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard reporting of stock option acquisition. The acquisition itself can be seen as a slightly positive sign of executive confidence, but it's not a major event.

Positives

• The acquisition of stock options by a key executive could signal confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and potential alignment of interests.

Stakeholder Impact

• Shareholders may view the stock option grant as a way to align management's interests with the company's performance.

Key Dates

Keywords

Form 4, CalciMedica, Stock Options, Eric W. Roberts, Chief Business Officer, SEC Filing, Beneficial Ownership